Peripheral Neuropathy Rehabilitation With Stabilometric Platforms (NEUROSTAB)

Официальное название

Evaluation and Rehabilitation of Patients With Peripheral Neuropathy Using Static and Dynamic Stabilometric Platforms: NEUROSTAB

Обзор

The goal of this clinical trial is to learn if the GeaMaster stabilometric platform can support rehabilitation and improve balance and walking ability in adults diagnosed with peripheral neuropathy. It will also evaluate whether the platform can provide objective and reliable data that match the results of standard clinical tests. The study will explore if brain and muscle activity, recorded during movement, can indicate how much motor learning and recovery has occurred. Peripheral neuropathies are disorders of the peripheral nerves and can have many causes, including diabetes, autoimmune diseases, toxins, or inherited conditions such as Charcot-Marie-Tooth disease. Symptoms may include reduced sensation, muscle weakness, poor reflexes, balance problems, and frequent falls. Since there are no approved drugs for many of these conditions, physical therapy is the main treatment option. The main questions this study aims to answer are: * Does using GeaMaster improve balance and walking better than traditional rehabilitation alone? * Are GeaMaster's stabilometric data consistent with standard balance and gait test scores? * Can movement-related evoked potentials be used as biomarkers to track and predict motor recovery? To answer these questions, researchers will compare two groups of patients. One group will receive traditional physiotherapy. The other group will receive the same therapy with the support of the GeaMaster platform. Both groups will follow the treatment for 4 weeks. A group of healthy volunteers will also be included for comparison. Participants will: * Be adults aged 18 to 80. Patients must have a diagnosis of peripheral neuropathy and a stable condition. * Be randomly assigned to a control group (traditional rehab) or experimental group (rehab with GeaMaster). * Visit the clinic for balance and walking tests at three time points: before treatment (T0), after 4 weeks of treatment (T1), and 1 month later (T2). * Complete clinical tests such as the Berg Balance Scale, 6-Minute Walk Test, 10-Meter Walk Test, Tinetti Scale, and Modified Barthel Index. * Be assessed using the GeaMaster platform for postural stability under both static and dynamic conditions. * Undergo neurophysiological tests using EEG and EMG to record brain and muscle activity during tasks like walking, writing, or drawing. Healthy volunteers will visit the clinic twice (5 days apart) to check how stable the GeaMaster measurements are over time. GeaMaster is a robotic platform that uses compressed air to gently move the support surface and challenge a patient's balance. It offers different levels of difficulty and provides real-time visual feedback. Its design avoids mechanical inertia, making movements feel more natural and safe for patients of all ages. The main outcome researchers will look for is a significant link between GeaMaster balance data and results of the Berg Balance Scale and the 10-Meter Walk Test. Other outcomes include performance on additional scales, the presence of balance improvements, risk of falling, and changes in movement-related brain signals.

Вмешательства

• Устройство Balance and postural rehabilitation using sensor-based stabilometric platform (GEAMASTER) under static and dynamic conditions
  This intervention consists of a structured postural rehabilitation program supported by the GEAMASTER stabilometric platform. The device provides real-time feedback on center-of-pressure shifts and enables both static and dynamic balance training through interactive visual tasks. Exercises include multi-directional weight shifting, stability control, and task-specific balance strategies. The platform integrates sensor-based tracking and allows fine-grained analysis of postural parameters, distin
• Другое Conventional balance and gait rehabilitation program
  This intervention consists of a standardized physiotherapy program aimed at improving postural control and gait in patients with peripheral neuropathy. The rehabilitation protocol includes stretching, weight-shifting exercises, balance training on foam or unstable surfaces, and obstacle navigation. Unlike the experimental intervention, this program does not use any technological or sensor-based feedback systems. The content, frequency, and duration of the sessions are matched to those of the exp
• Другое Stabilometric assessment in healthy volunteers
  This intervention involves a non-interventional assessment of healthy adult volunteers using the GEAMASTER stabilometric platform. The objective is to generate normative data for stabilometric parameters and to assess test-retest reliability of the device under static and dynamic conditions. Participants do not undergo any rehabilitation program or therapeutic intervention. The data collected will serve as a reference for interpreting pathological findings in patients with peripheral neuropathy.

Первичные конечные точки

• Correlation between sway area and sway path values and scores on the Berg Balance Scale [Срок оценки: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total]
• Correlation between sway area and sway path values and performance on the 10-Meter Walk Test [Срок оценки: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total]

Вторичные конечные точки (3)

• Correlation between additional stabilometric parameters (static balance, dynamic balance, fall risk, and mobility) and clinical outcomes [Срок оценки: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total]
• Temporal and frequency domain analysis of movement-related cortical potentials in upper and lower limbs [Срок оценки: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total]
• Comparison of movement-related cortical activity in upper versus lower limbs to evaluate motor learning effects [Срок оценки: From baseline (T0) to one-month post-treatment follow-up (T2), approximately 8 weeks total]

Критерии участия

Критерии включения

• Healthy subjects aged between 18 and 80 years
• Patients aged between 18 and 80 years with a diagnosis of peripheral neuropathy, according to international criteria
• Patients must be at an equivalent stage of disease
• Patients must be undergoing comparable and analogous treatments
• Pharmacological treatment stability during the last 6 months

Критерии исключения

• Severe comorbidity
• Presence of other neurological disorders or balance alterations due to other diseases (e.g., vestibular or cerebellar conditions)
• Pain with VAS >3 in any body region
• Orthopedic surgery within the past 6 months

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Да

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Двойное слепое

Основная цель

Лечение

Центры проведения

Список центров уточняется — проверьте первичный протокол.

Публикации

• Baratto L, Morasso PG, Re C, Spada G. A new look at posturographic analysis in the clinical context: sway-density versus other parameterization techniques. Motor Control. 2002 Jul;6(3):246-70. doi: 10.1123/mcj.6.3.246. PMID 12122219
• Scoppa F, Capra R, Gallamini M, Shiffer R. Clinical stabilometry standardization: basic definitions--acquisition interval--sampling frequency. Gait Posture. 2013 Feb;37(2):290-2. doi: 10.1016/j.gaitpost.2012.07.009. Epub 2012 Aug 11. PMID 22889928
• Wright DJ, Holmes PS, Smith D. Using the movement-related cortical potential to study motor skill learning. J Mot Behav. 2011;43(3):193-201. doi: 10.1080/00222895.2011.557751. PMID 21462065
• Shibasaki H. Cortical activities associated with voluntary movements and involuntary movements. Clin Neurophysiol. 2012 Feb;123(2):229-43. doi: 10.1016/j.clinph.2011.07.042. Epub 2011 Sep 8. PMID 21906995
• Prada V, Mori L, Accogli S, Rivarola M, Schizzi S, Hamedani M, Schenone A. Testing overwork weakness in Charcot-Marie-tooth disease: Is it true or false? J Peripher Nerv Syst. 2018 Jun;23(2):124-128. doi: 10.1111/jns.12270. Epub 2018 May 7. PMID 29693294
• Gess B, Baets J, De Jonghe P, Reilly MM, Pareyson D, Young P. Ascorbic acid for the treatment of Charcot-Marie-Tooth disease. Cochrane Database Syst Rev. 2015 Dec 11;2015(12):CD011952. doi: 10.1002/14651858.CD011952. PMID 26662471
• Rose KJ, Hiller CE, Mandarakas M, Raymond J, Refshauge K, Burns J. Correlates of functional ankle instability in children and adolescents with Charcot-Marie-Tooth disease. J Foot Ankle Res. 2015 Nov 5;8:61. doi: 10.1186/s13047-015-0118-1. eCollection 2015. PMID 26543504
• Pareyson D, Scaioli V, Laura M. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromolecular Med. 2006;8(1-2):3-22. doi: 10.1385/nmm:8:1-2:3. PMID 16775364

Идентификаторы

NCT: NCT07029620 · NEUROSTAB - PNC0000007 · #PNC0000007

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗